|
EIF2C1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.582040E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.353900E-02 |
| Normal-vs-Stage2 |
3.635800E-01 |
| Normal-vs-Stage3 |
3.981600E-03 |
| Normal-vs-Stage4 |
1.898290E-02 |
| Stage1-vs-Stage2 |
4.281800E-01 |
| Stage1-vs-Stage3 |
1.583360E-01 |
| Stage1-vs-Stage4 |
3.899200E-01 |
| Stage2-vs-Stage3 |
8.387500E-02 |
| Stage2-vs-Stage4 |
1.723980E-01 |
| Stage3-vs-Stage4 |
8.381400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.325950E-02 |
| Normal-vs-AfricanAmerican |
7.643200E-01 |
| Normal-vs-Asian |
3.663700E-02 |
| Caucasian-vs-AfricanAmerican |
3.302200E-02 |
| Caucasian-vs-Asian |
9.021600E-01 |
| AfricanAmerican-vs-Asian |
3.799600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.678200E-03 |
| Normal-vs-Female |
3.234400E-02 |
| Male-vs-Female |
3.528400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.527700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.869700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.386000E-02 |
| Normal-vs-Age(81-100Yrs) |
5.959900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.400400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.739600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.754000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.703600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.751200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.542600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.288200E-02 |
| Classical-VS-Follicular |
1.787990E-02 |
| Classical-VS-Other |
1.598450E-01 |
| Classical-VS-Normal |
1.290640E-01 |
| Tall-VS-Follicular |
7.488400E-01 |
| Tall-VS-Other |
6.685400E-01 |
| Tall-VS-Normal |
1.034190E-02 |
| Follicular-VS-Other |
5.857000E-01 |
| Follicular-VS-Normal |
6.358000E-03 |
| Other-VS-Normal |
7.486400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.962300E-02 |
| Normal-vs-N1 |
1.759690E-03 |
| N0-vs-N1 |
1.137610E-01 |
|
|
